These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5034421)

  • 1. Treatment of adrenocortical carcinoma with o,p'-DDD.
    Hoffman DL; Mattox VR
    Med Clin North Am; 1972 Jul; 56(4):999-1012. PubMed ID: 5034421
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical application of o.p' DDD to the case of adrenal cortex cancer].
    Naruse T; Sasaki T; Yamaoka T; Matsuoka K; Nekita H
    Horumon To Rinsho; 1970 Mar; 18(3):241-4. PubMed ID: 5464572
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of adrenocortical cancer treated with O,P'-DDD.
    Sakauchi N; Kumaoka S; Naruke T; Abe O; Kusama M
    Endocrinol Jpn; 1969 Apr; 16(2):287-90. PubMed ID: 5819718
    [No Abstract]   [Full Text] [Related]  

  • 4. [Our experience with o,p'-DDD in the treatment of hypercorticism].
    Mathieu De Fossey B; Luton JP; Bricaire H
    Ann Endocrinol (Paris); 1968; 29(1):93-102. PubMed ID: 4872638
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment with o,p'-DDD of inoperable forms of malignant adrenal gland neoplasms].
    Perevodchikova NI; Platinskiĭ LV; Kertsman VI
    Vopr Onkol; 1972; 18(11):24-9. PubMed ID: 4645074
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hormonally acitve cancer of the adrenal cortex treated with o, p'-DDD].
    Hartwig W; Massalski W; Kasperlik-Zaluska A; Migdalska B; Szamatowicz M; Jakowicki J
    Endokrynol Pol; 1968; 19(2):187-200. PubMed ID: 5668901
    [No Abstract]   [Full Text] [Related]  

  • 7. Remission in Cushing's syndrome with o,p'-DDD.
    Southren AL; Tochimoto S; Strom L; Ratuschni A; Ross H; Gordon G
    J Clin Endocrinol Metab; 1966 Mar; 26(3):268-78. PubMed ID: 4286017
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of O,p'DDD and aminoglutethimide on metastatic adrenocortical carcinoma.
    Bochner F; Lloyd HM; Roeser HP; Thomas MJ
    Med J Aust; 1969 Apr; 1(16):809-12. PubMed ID: 5769733
    [No Abstract]   [Full Text] [Related]  

  • 9. Metastatic adrenal cortical carcinoma: biochemical changes accompanying clinical regression during therapy with o,p'-DDD.
    Helson L; Wollner N; Murphy ML; Schwartz MK
    Clin Chem; 1971 Dec; 17(12):1191-3. PubMed ID: 4330217
    [No Abstract]   [Full Text] [Related]  

  • 10. ADRENOCORTICAL CARCINOMA TREATED WITH O,P' -DDD.
    MONTGOMERY DA; WELBOURN RB
    Br Med J; 1965 May; 1(5446):1356-8. PubMed ID: 14280300
    [No Abstract]   [Full Text] [Related]  

  • 11. Adrenal cortical carcinoma. Results of treatment with o,p'DDD in 138 patients.
    Hutter AM; Kayhoe DE
    Am J Med; 1966 Oct; 41(4):581-92. PubMed ID: 5923599
    [No Abstract]   [Full Text] [Related]  

  • 12. Steroids in urine from a patient with adrenocortical carcinoma after treatment with op'-DDD.
    Gustafsson JA; Lisboa BP
    Steroidologia; 1971; 2(1):27-37. PubMed ID: 5133742
    [No Abstract]   [Full Text] [Related]  

  • 13. o,p'DDD therapy in invasive adrenocortical carcinoma.
    Becker D; Schumacher OP
    Ann Intern Med; 1975 May; 82(5):677-9. PubMed ID: 1137262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feminizing adrenocortical carcinoma with hypertension.
    Solomon SS; Swersie SP; Paulsen CA; Biglieri EG
    J Clin Endocrinol Metab; 1968 May; 28(5):608-12. PubMed ID: 5653197
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemorrhage into the peritoneum in the course of treatment of adrenocortical carcinoma with o,p'-DDD and 5-fluorouracil].
    Kasperlik-Zaluska A; Migdalska B
    Endokrynol Pol; 1976; 27(1):111-5. PubMed ID: 1253752
    [No Abstract]   [Full Text] [Related]  

  • 16. TREATMENT OF ADRENOCORTICAL CANCER WITH O,P'-DDD.
    NETTO AD; WAJCHENBERG BL; RAVAGLIA C; PEREIRA VG; SHNAIDER J; PUPO AA; CINTRA AB
    Ann Intern Med; 1963 Jul; 59():74-8. PubMed ID: 14042612
    [No Abstract]   [Full Text] [Related]  

  • 17. Conversion of virilization to feminization in a young girl with adrenal cortical carcinoma.
    Halmi KA; Lascari AD
    Cancer; 1971 Apr; 27(4):931-5. PubMed ID: 5574080
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case of virilizing adrenocortical carcinoma. Treatment with Op'DDD].
    Roussel J; Hartemann P; Schoumacher P; Metz R; Leclere J; Kessler Y
    Ann Med Nancy; 1965 Nov; 4():971-7. PubMed ID: 5852075
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of chlodithane (o,p'-DDD) on transcortin binding ability in Itsenko-Cushing's disease].
    Tron'ko MD
    Fiziol Zh; 1970; 16(6):844-5. PubMed ID: 5520073
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of o,p'-DDD therapy on plasma cholesterol in adrenal carcinoma.
    MOLNAR GD; NUNN SL; TAUXE WN
    Proc Staff Meet Mayo Clin; 1961 Nov; 36():618-20. PubMed ID: 14475247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.